Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
Krakoff
L R
LR
Department of Medicine, Mount Sinai School of Medicine, USA.
Rajasekharaiah
V
V
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D002216:Captopril / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000503:physiopathology; D002986:Clinical Trials as Topic; D018450:Disease Progression; D006333:Heart Failure / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000517:prevention & control; D007674:Kidney Diseases / Q000503:physiopathology*; D009203:Myocardial Infarction / Q000188:drug therapy; D012084:Renin-Angiotensin System / Q000187:drug effects* / Q000502:physiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril